Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis1

American Journal of Nephrology

Volumn 6, Issue 3, 1986, Pages 206-211

  Wanner, Christoph ^a   Förstner Wanner, Sabine ^a   Schaeffer, Gunnar ^a   Schollmeyer, Peter ^a   Hörl, Walter H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Carnitine; Dialysis, continuous ambulatory peritoneal, intermittent peritoneal; Hemodialysis; Lipids

Indexed keywords

CARNITINE; CARNITINE ESTER; CHOLESTEROL; LIPID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIAGNOSIS; HEMODIALYSIS; HUMAN; KIDNEY; PERITONEAL DIALYSIS; PERITONEUM; THERAPY;

ADULT; AGED; CARNITINE; ESTERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS;

EID: 0022919258     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000167119     Document Type: Article

References (32)

1. Hörl, W.H.; Hörl. M.; Heidland, A.: Fettstoffwechselstörungen bei Nierenerkrankungen Pathogenetische Mechanismen. Klin. Wschr. 60: 327-336 (1982).
2. Böhmer. T.; Bergrcm, H.; Eiklid, K.: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet i: 126-128 (1978).
3. Fritz, I.B.; Marquis, N.R.: The role of acylcamitine esters and carnitine palmityliransferase in the transport of fatty acyl groups across mitochondrial membranes. Proc. natn. Acad. Sci. USA 54: 1226-1233 (1965).
4. Lacour, B.; DiGiulio, S.; Chanard, J.; Ciancioni, C.; Haguet, M.; Lebkiri, B.; Basile, C.; Drüeke, T.; Assan, R.; Funck-Brentano. J.L.: Carnitine improves lipid anomalies in hemodialysis patients. Lancet ii: 763-765 (1980).
5. Leschke, M.; Rumpf, K.W.; Eisenhauer, T.; Becker, K.; Bock, U.; Scheler, F.: Serumspiegel und Urinausscheidung von L-Carnitin bei Patienten mit normaler und eingeschränkter Nierenfunktion. Klin. Wschr. 62: 274-277 (1984).
6. Basile, C.; Lacour, B.; DiGiulio, S.; Drüeke, T.: Effect of oral carnitine supplementation on disturbances of lipid metabolism in the uremic rat. Nephron 39: 50-54 (1985).
7. Rössle, C.; Kohse, K.P.; Franz, H.-E.; Fürst, P.: An improved method for the determination of free and esterified carnitine. Clinica chim. Acta 149: 263-268 (1985).
8. Bergmeyer, H.V.: Methoden der enzymatischen Analyse, pp.1491-1890 (Verlag Chemie, Weinheim 1974).
9. Hörl, W.H.; Echsel, E.; Hohenegger, M.: The key role of sex dependency on kidney citrate metabolism in the rat. Res. exp. Med. 185: 69-75 (1985).
10. Bellinghieri, G.; Savica, V.; Mallamace, A.; DiStefano, C.; Consolo, F.; Spagnoli, L.G.; Villaschi, S.; Palmieri, G.; Corsi, M.; Maccari, F.: Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am. J. clin. Nutr. 38: 523-531 (1983).
11. Savica, V.; Bellinghieri, G.; DiStefano, C.; Corvaja, E.; Consolo, F.; Corsi, M.; Maccari, F.; Spagnoli, L.G.; Villaschi, S.; Palmieri, G.: Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 35: 232-236 (1983).
12. Vacha, G.M.; Giorcelli, G.; Siliprandi, N.; Corsi, M.; Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol. Am. J. clin. Nutr. 38: 532-540 (1983).
13. Leschke, M.; Rumpf, K.W.; Eisenhauer, T.; Fuchs, C.; Becker, K.; Köthe, U.; Scheler, F.: Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney int. 24: suppl. 16, pp.S143-S146 (1983).
14. Bertoli, M.; Battistella, P.A.; Vergani, L.; Naso, A.; Gasparotto, M.L.; Romagnoli, G.F.; Angelini, C.: Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Am. J. clin. Nutr. 34: 1496-1500 (1981).
15. Gusmano, R.; Oleggini, R.; Perfumo, F.: Plasma carnitine concentrations and dyslipidemia in children on maintenance hemodialysis. J. Pediat. 99: 429-432 (1981).
16. Fagher, B.; Thysell, H.; Nilsson-Ehle, P.; Monti, M.; Olsson, L.; Eriksson, M.; Lindstedt, S.; Lindholm, T.: The effect of D, L-camitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic function in hemodialysis patients. Acta med. scand. 212: 115-120 (1982).
17. Moorthy, A.V.; Rosenblum, M.; Rajaram, R.; Shug, A.L.: A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am. J. Nephrol. 3: 205-208 (1983).
18. Mingardi, G.; Bizzi, A.; Cini, M.; Licini, R.; Mecca, G.; Garattini, S.: Carnitine balance in hemodialyzed patients. Clin. Nephrol. 13: 269-270 (1980).
19. Bartel, L.L.; Hussey, J.L.; Shrago, E.: Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am. J. clin. Nutr. 34: 1314-1320 (1981).
20. Bartel, L.L.; Hussey, J.L.; Shrago, E.: Effect of dialysis on serum carnitine, free fatty acids, and triglyceride levels in man and the rat. Metabolism 31: 944-947 (1982).
21. Rössle, C.; Kohse, K.P.; Graser, T.A.; Glöggler, A.; Franz, H.-E.; Fürst. P.: Plasma-Konzentrationen von Camitin und dessen Vorstufe N-6-Trimethyllysin bei Dialysepatienten im Vergleich zu Gesunden (Abstract). Infusionstherapie 12: 10 (1985).
22. Battistella, P.A.; Angelini, C.; Vergani, L.; Bertoli, M.; Lorenzi, S.: Carnitine deficiency induced during haemodialysis (Letter). Lancet i: 939 (1978).
23. Bizzi, A.; Cini, M.; Garattini, S.; Mingardi, G.; Licini, L.; Mecca, G.: L-carnitine addition to haemodialysis fluid prevents plasma-camitine deficiency during dialysis (Letter). Lancet i: 882 (1979).
24. Guamieri, G.F.; Ranieri, F.; Toigo, G.; Vasile, A.; Ciman, M.; Rizzoli, V.; Moracchiello, M.; Campanacci, L.: Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am. J. clin. Nutr. 33: 1489-1492 (1980).
25. Weschler, A.; Aviram, M.; Levin, M.; Better, O.S.; Brock, J.G.: High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialyses. Nephron 38: 120-124 (1984).
26. Ccderblad, G.: Plasma carnitine and body composition. Clinica chim. Acta 67: 207-212 (1976).
27. Maebashi, M.; Kawamura, N.; Sato, M.; Imamura, A.; Yoshinaga, K.: Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia. Lancet ii: 805-807 (1978).
28. Maebashi, M.; Imamura, A.; Yoshinaga, K.; Sato, T.; Funyu, T.; Ishidoya, Y.; Hirayama, N.: Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis. Tohoku J. exp. Med. 139: 33-42 (1983).
29. Albertazzi, A.; Capclli, P.; DiPaolo, B.; Pola, P.; Tondi, P.; Vaccarino, O.: Endocrine-metabolic effects of L-carnitine in patients on regular dialysis treatment. Proc. Eur. Dial. Transplant Ass. 19: 302-307 (1982).
30. Bougneres, P.F.; Lacour, B.; DiGiulio, S.; Assan, R.: Hypolipaemic effect of carnitine in uraemic patients (Letter). Lancet i: 1401-1402 (1979).
31. McGarry, J.D.; Robles-Valdes. C.; Foster, D.W.: Role of carnitine in hepatic ketogenesis. Proc. natn. Acad. Sci. USA 72: 4385-4388 (1975).
32. Penn, D.; Schmidt-Sommerfeld, E.: Camitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis. Metabolism 32: 806-809 (1983).